Novel Insights into Stem Cell and Bio-Markers Conference

Oct 09-10, 2019

Abu Dhabi, United Arab Emirates (UAE)

Conference on Stem Cells and BioMarkers in 2019 in Abudhabi, UAE

LexisConferences is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. Stem Cells and BioMarkers Conference famously known as Stem Cell 2019 Abu Dhabi.

It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques through stem cells and biomarkers with different approach. This meet enlightens the latest treatment advancements in Stem cell biomarkers research around the globe who concentrates on growth about ongoing advances like first stage analysis to treatment etc. This is the best chance to achieve the biggest array of members.

This conference invites Cell biology and Stem cell researchers, Oncologists, Academicians, Physicians, Academic scientists, Radiologists, Chemo therapists, Industry professionals, Head of the departments, Directors, Clinical Professionals, Young researchers, Postgraduates, Trainees and all stem cell biomarkers Researchers. It also gives the best opportunity to the Business professionals to represent their company.

Stem Cells 2019 Abu Dhabi cordially conducted by the LexisConferences in Abu Dhabi, UAE on Oct 09-10, 2019 mainly focuses on cause and cure for genetic disorders and treatment through the regenerative medicine . The congress runs with the theme “Building Blocks of Life - Breaking the Barriers through Stem Cell Research and Biomarker”.

Ten years in public health

On the beginning of the 21st century, at the point when the Millennium Development Goals were advanced as the larger structure for improved collaboration, the epidemics of Acquired Immune Deficiency Syndrome (AIDS), Tuberculosis, and Malaria were raging out of the control. The yearly number of preventable maternal and youth death had been stuck over 10 million for decades. Crisis activity was required. Then the global health initiatives that were set up to pursue the health-related goals eventually had a tremendous effect, readily measured in the number of interventions delivered, deaths averted and lives prolonged. All of these initiatives depended on well-functioning health systems to deliver medical commodities, yet rarely made the strengthening of health systems an explicit or funded objective. In many cases, weak public health infrastructures were simply bypassed through the construction of parallel systems for the procurement and distribution of interventions, for laboratory services, and for budgeting, financing, and reporting. Source from World Health Organization (WHO)

Details of Stem Cell 2019 Abu Dhabi Conference, UAE :

Conference Name Place Date
Stem Cell 2019 Abu Dhabi Abu Dhabi, UAE October 9-10, 2019


Stem Cell Conferences | LexisConferences Conferences | Abu Dhabi | UAE | Conference | LexisConferences Middle East Conferences

The worldwide stem cell market expected is required to enlist a CAGR of 15% amid the estimated time of 2018 – 2023. stem cells are unspecialized cells, which have a surprising property of forming into various types of cell composes, amid their initial life and development period inside the human body. When they isolate, every cell can possibly remain either the same or change into a particular cell compose. Along these lines, under certain physiologic or trial conditions, these cells can be instigated to end up tissue-particular or organ-particular with unique capacities.



Based on type, the worldwide undifferentiated organism treatment showcase is separated into two noteworthy classifications, to be specific, allogeneic foundational microorganism treatment and autologous undeveloped cell treatment. The allogeneic foundational microorganism treatment portion is required to order the biggest offer in the worldwide undifferentiated organism treatment showcase in 2016. This expansive offer can principally be ascribed to the rising commercialization of allogeneic immature microorganism treatment items, more extensive restorative utilizations of allogeneic undifferentiated organisms, simple generation scale-up process, and developing number of clinical preliminaries identified with allogeneic undeveloped cell treatments.

The Global Stem Cell Market In Million's




Stem Cells and Bio-Markers Conference famously known as Stem Cell 2019 Abu Dhabi.

Magnus S Magnusson
University of Iceland


Magnus S Magnusson is a Research Professor, completed his PhD in 1983 from the University of Copenhagen. He has created the T-pattern model and detection algorithms implemented in THEME. He has focused on real-time organization of behavior, co-directed a

Researches :

  • Anthropology, Pharmacology
Bhuvarahamurthy V
University of Madras


Bhuvarahamurthy V has research and teaching experience gained in a prestigious institution including Harvard Medical School (Boston, USA), Weizmann Institute of Science (Israel), and Humboldt University (Berlin, Germany).

Researches :

  • His research areas are cancer genetics, metabolic disorder, cardiovascular and neurobiology. Skilled in assay development, cell culture, molecular biology, biochemistry, and KO mouse model creation, Human Genetics and Genomics. Excellent skills include teaching, presentation, collaboration and working in a team. Experienced in working with the supervisory role (experiment planning and oversee the plan execution), highly inquisitive, creative, and resourceful. Also experienced in writing validation protocols for biotech, medical devices and managing the protocol to completion."
Nefize Sertac Kip
Sema4, USA


She is a pathologist who has completed her training at Mayo Clinic, Rochester MN five years ago. She has triple boarded for anatomic, clinical and molecular genetics pathology. She is currently working as the Director of Oncology at Sema4 Genomics Laborat

Rossana Thire
University of Rio de Janeiro - UFRJ


She is currently full-time professor at Program of Metallurgical and Materials Engineering (PEMM/COPPE), Federal University of Rio de Janeiro - UFRJ, Brazil. She is the head of Biomaterial area of PEMM/COPPE/UFRJ, leader of the “Technology in Biopolymers”

Rui Damazio Alvites
University Do Porto

Researches :

  • Mesenchymal Stem Cells, Olfactory Mucosa Mesenchymal Stem Cells, Biomaterials, Peripheral Nerve Injury and Regeneration, Veterinary Medicine, Translational Medicine, One Health

Program Overview

Our Collaborations, Sponsors, Media Partners